This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Pharmathen S.a.. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Alexandros Strongilos: Innovator in Pharmaceutical Processes
Introduction
Alexandros Strongilos is a notable inventor based in Koropi, Greece. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of specific compounds that are crucial for medical applications. His innovative approach has led to the development of a unique process that enhances the efficiency of drug production.
Latest Patents
Strongilos holds a patent for a process titled "Process for the preparation of O-desmethyl-venlafaxine and salts thereof." This invention relates to a novel method for synthesizing O-desmethyl venlafaxine (ODV) and its pharmaceutically acceptable salts. The process involves the provision of a spiro-venlafaxine compound as an intermediate, followed by its conversion into ODV free base in a one-pot process. Additionally, the invention includes methods for preparing crystalline salts of ODV-succinate and ODV-oxalate.
Career Highlights
Throughout his career, Strongilos has worked with reputable companies in the pharmaceutical industry, including Pharmathen S.A. and Pro-Actina S.A. His experience in these organizations has allowed him to refine his skills and contribute to advancements in drug formulation and production.
Collaborations
Strongilos has collaborated with esteemed colleagues such as Theoharis V Koftis and Ioanna Georgopoulou. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pharmaceutical sector.
Conclusion
Alexandros Strongilos is a distinguished inventor whose work in pharmaceutical processes has made a significant impact on drug development. His innovative methods and collaborations continue to advance the field, showcasing the importance of creativity and expertise in the pharmaceutical industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile